Expand the knowledge about the clinical phenotypes associated with pathogenic or likely pathogenic variants in the SCN1A gene.
Methods
The study was carried out in 15 patients with SCN1A variants. The complete phenotype of the patients was evaluated. A systematic search was carried out in the scientific literature for those unexpected symptoms.
Results
Ten patients showed a missense variant, whereas the remaining showed different loss-of-function variants. Twelve (80%) had Dravet syndrome. Two (13.3%) had Epilepsy with febrile seizures plus. Three (20%) presented an atypical phenotype. One of them was developmental and epileptic encephalopathy with arthrogryposis, the other Dravet syndrome and movement disorder, and lastly one patient had Dravet syndrome and malformations of the cortical development.
Conclusion
The exhaustive assessment of patients with pathogenic alterations detected in massive sequencing can help us to expand the phenotype, understand the etiopathogenesis associated with each genetic abnormality, and thus improve the prognosis and management of future patients.
de LangeIMKoudijsMJvan’t SlotR, et al. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. Epilepsia. 2018;59:690‐703.
2.
YuFHMantegazzaMWestenbroekRE, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci. 2006;9:1142‐1149.
3.
OgiwaraIMiyamotoHMoritaN, et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci. 2007;27:5903‐5914.
4.
CatterallWAKalumeFOakleyJC. Nav1.1 channels and epilepsy. J Physiol. 2010;588:1984‐1959.
5.
KalumeFYuFHWestenbroekRESheuerTCatterallWA. Reduced sodium current in Purkinje neurons from NaV1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci. 2007;27:11064‐11074.
6.
HanSTaiCWestenbroekRE, et al. Autistic behavior in Scn1a+/– mice and rescue by enhanced GABAergic transmission. Nature. 2012;489;385‐390.
7.
BrunklausASchorgeSSmithAD, et al. SCN1A variants from bench to bedside-improved clinical prediction from functional characterization. Human Mutat. 2019;41(2):363‐374.
8.
SchefferINabboutR. SCN1A-related phenotypes: epilepsy and beyond. Epilepsia. 2019;60(S3):S17‐S24.
9.
MeiDCeticaVMariniCGuerriniR. Dravet syndrome as part of the clinical and genetic spectrum of sodium cannel epilepsies and encephalopathies. Epilepsia. 2019;60(S3):S2 − SS7.
10.
Carranza RojoDHamiwkaLMcMahonJM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology. 2011;77(4):380‐383.
11.
HiroseSSchefferIEMariniC, et al. SCN1A testing for epilepsy: application in clinical practice. Epilepsia. 2013;54(5):946‐952.
12.
MengHXuHQYuL, et al. The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype. Hum Mutat. 2015;36:573‐580.
13.
SadleirLGMountierEIGillD, et al. Not all SCN1A epileptic encephalopathies are Dravet syndrome: early profound Thr226Met phenotype. Neurology. 2017;89:1035‐1142.
14.
SpagnoliCFrattiniDRizziSSalernoGGFuscoC. Early infantile SCN1A epileptic encephalopathy: expanding the genotype-phenotype correlations. Seizure. 2019;65:62‐64.
15.
BeckVCHullJMIsomLL. Beyond Dravet syndrome: characterization of a novel, more severe SCN1A–linked epileptic encephalopathy. Epilepsy Curr. 2019;19(4): 266‐268.
16.
JaberDGitiauxCBlessonS, et al. De novo mutations of SCN1A are responsible for arthrogryposis broadening the SCN1A-related phenotypes. J Med Genet. 2020;20:1‐6.
17.
JiangTShenYChenH, et al. Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome. Medicine (Baltimore). 2018;97(50):e13565.
18.
SymondsJDZuberiSMStewartK, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain. 2019;142:2303‐2318.
19.
MillerIO, Sotero de Menezes MA. SCN1A-related seizure disorders. In: AdamMP, Ardinger HA, Pagon RA, et al, eds. GeneReviews®. 1993–2021.University of Washington; 2018.
20.
DepienneCTrouillardOSaint-MartinC, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet. 2009;46(3):183‐191.
21.
RichardsSAzizNBaleS, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405‐424.
22.
MartinezFCaro-LlopisARoselloM, et al. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing. J Med Genet. 2017;54(2):87‐92.
23.
ZuberiSMBrunklausABirchR, et al. Genotype-phenotype associations in SCN1A-related epilepsies. Neurology. 2011;76(7):594‐600.
24.
CatarinoCBLiuJYWLiagkourasI, et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain. 2011;134(Pt10):2982‐3010.
25.
RilstoneJJCoelhoFMMinassianBAAndradeDM. Dravet syndrome: seizure control and gait in adults with different SCN1A mutations. Epilepsia. 2012;53(8):1421‐1428.
26.
KobayashiYTohyamaJKatoM, et al. High prevalence of genetic alterations in early-onset epileptic encephalopathies associated with infantile movements disorders. Brain Dev. 2016;38(3):285‐292.
27.
BereckiGBrysonATerhagJ, et al. SCN1A gain of function in early infantile encephalopathy. Ann Neurol. 2019;85:514‐525.
28.
OhashiTAkasakaNKobayashiY, et al. Infantile epileptic encephalopathy with a hyperkinetic movement disorder and hand stereotypies associated with a novel SCN1A mutation. Epileptic Disord. 2014;16:208‐212.
29.
OhtsukaYOhmoriIOginoT, et al. Paroxysmal movement disorders in severe myoclonic epilepsy in infancy. Brain Dev. 2003;25(6):401‐405.
30.
BadhekaRBaradKNSankhlaCS. Pediatric movement disorders. Neurol India.2018;66(Suppl):s59‐s67.
31.
PearsonTSPonsR. Movement disorders in children. Continuum (Minneap Minn). 2019;25(4):1099‐1120.
32.
SkjeiKLChurchEWHardingBN. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. J Neurosurg Pediatr. 2015:16:668‐674.
33.
BarbaCParriniECorasR, et al. Co-occurring malformations of cortical development and SCN1A gene mutations. Epilepsia. 2014;55(7):1009‐1019.
StrianoPMancardiMMBiancheriR, et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia. 2007;48(6):1092‐1096.
36.
Le GalFKorffCMMonso-HinardC, et al. A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation. Epilepsia. 2010; 51(9):1915‐1918.
37.
RenierWORnekawekK. Clinical and neuropathologic findings in a case of severe myoclonic epilepsy of infancy. Epilepsia. 1990;31:287‐291.
38.
JansenPRDremmenMvan den BergA, et al. Incidental findings on brain imaging in the general pediatric population. N Engl J Med. 2017;377: 1593‐1593.
39.
HansenMGreenopKRBourkeJ, et al. Intellectual disability in children conceived using assisted reproductive technology. Pediatrics. 2018;142(6): e20181269.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
